SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novavax earns $125 mln milestone as Sanofi launches Phase 3 flu-COVID combo vaccine trial in Europe

Novavax said it earned a $125 mln milestone payment after the fifth patient was dosed in Sanofi's Ph

NVAXSNY

Related stories